Comparative analysis of gene expression in human blood cells and in rhabdomyosarcoma cells pretreated with antimutagens

Dokl Biochem Biophys. 2014:457:160-2. doi: 10.1134/S1607672914040139. Epub 2014 Aug 30.

Authors

G D Zasukhina¹, A A Shishkina, I M Vasilyeva, E A Rogozhin, V F Mikhajlov, N F Raeva, L V Shulenina, S P Gromov, M V Alfimov

Affiliation

¹ Vavilov Institute of General Genetics, Russian Academy of Sciences, ul. Gubkina 3, Moscow, 119991, Russia, Zasukhina@viigg.ru.

PMID: 25172342
DOI: 10.1134/S1607672914040139

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Antimutagenic Agents / pharmacology*
Benzodiazepines / pharmacology*
Cell Line, Tumor
Gene Expression Regulation, Neoplastic*
Humans
Inhibitor of Apoptosis Proteins / genetics
Inhibitor of Apoptosis Proteins / metabolism
Lymphocytes / drug effects
Lymphocytes / metabolism*
Matrix Metalloproteinases / genetics
Matrix Metalloproteinases / metabolism
MicroRNAs / genetics
MicroRNAs / metabolism
NF-kappa B / genetics
NF-kappa B / metabolism
Rhabdomyosarcoma / metabolism*
Tissue Inhibitor of Metalloproteinase-1 / genetics
Tissue Inhibitor of Metalloproteinase-1 / metabolism
Tissue Inhibitor of Metalloproteinase-2 / genetics
Tissue Inhibitor of Metalloproteinase-2 / metabolism

Substances

Antimutagenic Agents
Inhibitor of Apoptosis Proteins
MIRN21 microRNA, human
MIRN34 microRNA, human
MicroRNAs
NF-kappa B
Tissue Inhibitor of Metalloproteinase-1
Tissue Inhibitor of Metalloproteinase-2
Benzodiazepines
Matrix Metalloproteinases